(Q87123297)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Christophe Baudouin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Georges Deschenes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Chantal Loirat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Marina Charbit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Geneviève Guest

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Patrick Niaudet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

9 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

314-320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

Long-term ocular manifestations in nephropathic cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

Ocular changes in long-term evolution of infantile cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

Removal of corneal crystals by topical cysteamine in nephropathic cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

Gel formulations for treatment of the ophthalmic complications in cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

Confocal microscopy of the cornea in nephropathic cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

Evaluation of treatment with cysteamine eyedrops for cystinosis with confocal microscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

In vivo confocal microscopy and polarizing microscopy of the cornea in a patient with nephropathic cystinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.12.298

10.1016/J.YMGME.2013.12.298

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440466%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference